JDJames Dempsey

James Dempsey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James Dempsey has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    What Cochlear Implantation with Attempted Hearing Preservation in Widened Vestibular Aqueduct Adds to Understanding About the Etiology and Pathogenesis of Hearing Loss: A Systematic Review

    by Nathan Walker, Hawa Ould-Ahmed, Haroon Saeed, James Dempsey, Matthew Sperrin, Jaya Nichani, Iain A. Bruce

    Widened vestibular aqueduct (WVA) is the commonest congenital inner-ear malformation associated with childhood sensorineural hearing loss. Proposed pathophysiological mechanisms include abnormal endolymph–perilymph pressure regulation, hyperproteinaceous perilymph and impaired ionic homeostasis, particularly in SLC26A4-related disease. These vulnerabilities have raised concerns about the feasibility of hearing preservation cochlear implantation (HPCI).The study aims to evaluate HPCI outcomes in children with WVA and identify prognostic factors that may clarify underlying pathophysiology.A Preferred Reporting Items for Systematic Reviews and Meta-Analyses–compliant systematic review (PROSPERO CRD420251128410) of MEDLINE, Embase, Cochrane Library, and CINAHL from inception to November 2025 identified studies reporting pre- and postoperative unaided thresholds in WVA cochlear implant recipients. Two reviewers independently screened and extracted data. Heterogeneity in outcome definitions required narrative synthesis.Five observational studies including 58 WVA patients (228 total across all cohorts) met inclusion criteria. Hearing preservation ranged from 20%-83% using a variation of outcome criteria. Studies reported improved outcomes with round-window insertion, soft-surgery techniques, and lateral-wall electrodes. In the largest regression analysis, WVA independently predicted poorer preservation. SLC26A4-related WVA did not preclude preservation, and several cohorts reported small postoperative low-frequency threshold changes (

  • Open Access

    Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities

    by James Dempsey, Jessica Daniels, Roulla Katiri, Sophie Thomas, Aleksandra Metryka, Mira de Kruijf, Stuart Wilkinson, Simon A. Jones, Iain A. Bruce

    Background: The mucopolysaccharidoses are a group of rare, inherited metabolic disorders. MPS II is a X-linked recessive disease, also known as Hunter syndrome. Clinical manifestations include upper and lower respiratory tract, and head and neck pathologies influencing quality of life, morbidity, and mortality. Medical and surgical intervention outcomes for MPS are reported inconsistently, creating a challenge when synthesising and contrasting evidence. This study set out to address the inconsistency in outcome measurement in this field. International recommendations for developing a core outcome set were adopted. Available data from qualitative studies and outcomes from a modified e-Delphi surveys were used to develop a list of candidate outcomes for consideration. Three consensus meetings with patients diagnosed with MPS II alongside their parents/carers were ran to help finalise a list of outcome domains. Results: Survival, airway obstruction, and quality of life were outcomes identified as important to always measure in all MPS II clinical trials and/or in clinical practice. Other outcomes for younger children included swallowing difficulties, cognitive development, ability to participate in education, and communication. The adolescent group included safety of chewing and swallowing, complications of anaesthesia, sleep quality and apnoea, nasal problems, and chronic otitis media. The adult group identified sleep apnoea, and hearing, as additional outcomes to measure. Conclusions: A novel methodology for determining a core outcome set in rare diseases has been recommended. Both functional and quality of life outcomes were identified by the three age groups of individuals and/or their parents. Adoption of these sets of outcomes in future clinical trials and/or clinical practice will enable comparison of outcomes reported.


  • Progressive hearing loss in childhood – shifting from reactive to dynamic management

    by James Dempsey, Karolina Kluk-De Kort, Iain A Bruce, Jaya Nichani

    Advances in worn and implantable hearing device technology is such that hearing can now be successfully (re)habilitated from mild to profound hearing loss. Whilst hearing services have access to the latest digital hearing devices, bone conduction and cochlear implants, two main research and clinical challenges remain within the pediatric population, namely matching the device to the hearing loss and needs of the individual (e.g. borderline cochlear implant candidacy), and early identification to facilitate timely intervention across the pediatric life span. Deteriorating and later-onset hearing loss are exemplars of the challenges faced.

  • Open Access

    Exploring the burden of paediatric acute otitis media with discharge in the UK: a qualitative study

    by Elliot Heward, Judith Lunn, James Birkenshaw-Dempsey, John Molloy, Rachel Isba, Darren M Ashcroft, Alastair D Hay, Jaya R Nichani, Iain A Bruce

    Background: Acute otitis media with discharge (AOMd) results from a tympanic membrane perforation secondary to a middle ear infection. Currently, the impact of AOMd on children and young people (CYP) and their families is not well understood. There is also a need to explore the experience of healthcare professionals in treating AOMd. Interviews with CYP and their parents, and focus groups with medical professionals, were conducted to explore these objectives.Methods: A total of 26 parents of CYP (age range: 7 months to 15 years) with a history of AOMd (within the last year) and 28 medical professionals were recruited across the UK between August 2023 and March 2024. Healthcare professionals were from primary care (n=17), ear, nose and throat (ENT) (n=7) and emergency medicine (n=4) backgrounds. Thematic analysis was performed independently by three reviewers.Results: The majority of CYP (n=25/26) (96.2%) had suffered from multiple episodes of AOMd. AOMd has a physical, psychological, educational, financial and social impact on CYP and their parents. Parents found accessing healthcare services and information difficult, which increased parental anxiety. Antibiotic overuse was also a concern among parents. The majority of general practitioners and emergency care staff described using oral amoxicillin, compared with ENT doctors who predominantly prescribed topical antibiotics.Conclusions: AOMd has a significant impact on CYP and their parent’s daily lives. Need for clear, easily accessible patient information was identified as a priority by the parents of CYP with AOMd. Evidence-based management guidelines should be developed once high-quality evidence is available.Trial registration number: ISCTRN43760.


  • Open Access

    Protocol for the Paediatric Otorrhoea Study (POSt): a multi-methods study to understand the burden of paediatric otorrhoea in the UK

    by Elliot Heward, James Dempsey, Judith Lunn, John Molloy, Rachel Isba, Matthew Carr, Darren Ashcroft, Alastair D Hay, Jaya R Nichani, Iain A Bruce

    Introduction Paediatric otorrhoea (PO) refers to the leakage of fluid through a perforation in the ear drum, resulting from an infection of the middle ear of a child or young person (CYP). PO frequently results in hearing loss which may lead to developmental delay, restricted communication and reduced educational attainment. Epidemiological information for PO is largely derived from low-income countries. The aim of this study will be to establish the incidence of PO within the UK and to understand the impact of PO on CYP and their families’ everyday lives. It will build the foundations for a randomised controlled trial investigating the best antibiotic treatment for PO. Methods and analysis The study will consist of two work packages. (1) Data from the Clinical Practice Research Datalink (CPRD), January 2005 to July 2021, will be used to determine the incidence of patient presentations with PO to primary care in the UK. It will also explore the current antimicrobial prescribing practice for PO in primary care. (2) Thirty semi-structured interviews will be conducted from 13 July to 31 October 2023 with CYP and their parents/carers to help identify the impact of PO on everyday life, the patient journey and how service users define treatment success. Three medical professional focus groups will be used to understand the current management practice, how treatment success is measured and acceptability to randomise patients. Thematic analysis will be used. Ethics and dissemination The Health Research Authority, The Health and Social Care Research Ethics Committee (23/NI/0082) and the CPRD’s research data governance panel (22_002508) reviewed this study. Results will be disseminated at medical conferences, in peer-reviewed journals and via social media. The study will cocreate a webpage on healthtalk.org, with the Dipex Charity, about PO to ensure members of the public can learn more about the condition. Trial registration number ISRCTN46071200.


  • Year One of the First Ever MR-IGRT Program: System Practicality and Future Implications

    by S. Mutic, J.R. Olsen, O.L. Green, R. Kashani, H. Li, V.L. Rodriguez, H. Wooten, T. Zhao, D. Yang, J.D. Bradley, et al.

  • SU‐E‐J‐142: Performance Study of Automatic Image‐Segmentation Algorithms in Motion Tracking Via MR‐IGRT

    by Y Feng, I Kawrakow, J. Olsen, P. Parikh, C Noel, H Wooten, D Du, J Dempsey, S Mutic, Y Hu

    Purpose: Evaluate commonly used segmentation algorithms on a commercially available real‐time MR image guided radiotherapy (MR‐IGRT) system (ViewRay), compare the strengths and weaknesses of each method, with the purpose of improving motion tracking for more accurate radiotherapy.Methods: MR motion images of bladder, kidney, duodenum, and liver tumor were acquired for three patients using a commercial on‐board MR imaging system and an imaging protocol used during MR‐IGRT. A series of 40 frames were selected for each case to cover at least 3 respiratory cycles. Thresholding, Canny edge detection, fuzzy k‐means (FKM), k‐harmonic means (KHM), and reaction‐diffusion level set evolution (RD‐LSE), along with the ViewRay treatment planning and delivery system (TPDS) were included in the comparisons. To evaluate the segmentation results, an expert manual contouring of the organs or tumor from a physician was used as a ground‐truth. Metrics value of sensitivity, specificity, Jaccard similarity, and Dice coefficient were computed for comparison.Results: In the segmentation of single image frame, all methods successfully segmented the bladder and kidney, but only FKM, KHM and TPDS were able to segment the liver tumor and the duodenum. For segmenting motion image series, the TPDS method had the highest sensitivity, Jarccard, and Dice coefficients in segmenting bladder and kidney, while FKM and KHM had a slightly higher specificity. A similar pattern was observed when segmenting the liver tumor and the duodenum. The Canny method is not suitable for consistently segmenting motion frames in an automated process, while thresholding and RD‐LSE cannot consistently segment a liver tumor and the duodenum.Conclusion: The study compared six different segmentation methods and showed the effectiveness of the ViewRay TPDS algorithm in segmenting motion images during MR‐IGRT. Future studies include a selection of conformal segmentation methods based on image/organ‐specific information, different filtering methods and their influences on the segmentation results.Parag Parikh receives research grant from ViewRay.Sasa Mutic has consulting and research agreements with ViewRay.Yanle Hu receives travel reimbursement from ViewRay.Iwan Kawrakow and James Dempsey are ViewRay employees.

  • SU-FF-J-130: PET Free Breathing Motion Artifact Reduction Using List-Mode Data

    by T Zhao, P Parikh, J Hubenschmidt, S Mutic, J Dempsey, K Malinowski, J Bradley, D Low

  • SU-FF-J-95: Validation of the 5D Breathing Motion Model Using a 64-Slice CT Scanner

    by D Low, P Parikh, J Hubenschmidt, S Mutic, J Dempsey, J Bradley

  • WE-D-ValB-05: Sinogram-Based Respiratory Gating for 5D PET

    by D Low, W Lu, P Parikh, J Hubenschmidt, J Dempsey, P Grigsby, S Mutic, J Bradley